Bruno Sarmento
@brunocsarmento.bsky.social
Principal Investigator and BoD @i3S_UPorto, President-elect @CRSScience, Editor @EditorsEJPS, Special Issues Editor @DDTReMedia, Husband, Father of 3, World traveller
Congratulations @claudia-martins.bsky.social ! We are very proud of you!
L'Oréal Portugal announced the recipients of the 2025 Medals of Honor for Women in Science: two #i3S researchers, Inês Alves and Cláudia Martins, were granted a medal🤩
The other two awardees hail from #FEUP, so #UPorto is clearly this edition's grand winner👏
📰👀👇
#i3Sawards #peopleofi3S #LorealMedals
The other two awardees hail from #FEUP, so #UPorto is clearly this edition's grand winner👏
📰👀👇
#i3Sawards #peopleofi3S #LorealMedals
Cientistas da U.Porto dominam Medalhas de Honra L’Oréal 2025
Inês Alves, Cláudia Martins, Ana Filipa Esteves e Fátima Santos vão receber 15 mil euros, cada, para desenvolver os respetivos projetos.
tinyurl.com
September 16, 2026 at 4:49 PM
Congratulations @claudia-martins.bsky.social ! We are very proud of you!
Meet our group member Camino Garcia-Blasco.
Camino is a visiting PhD Student from @ehu.eus working on development of MSC-based therapies for IBD. You can find more about her work at i3s.up.pt/personal-inf...
@i3suporto.bsky.social
Camino is a visiting PhD Student from @ehu.eus working on development of MSC-based therapies for IBD. You can find more about her work at i3s.up.pt/personal-inf...
@i3suporto.bsky.social
September 16, 2026 at 11:47 AM
Meet our group member Camino Garcia-Blasco.
Camino is a visiting PhD Student from @ehu.eus working on development of MSC-based therapies for IBD. You can find more about her work at i3s.up.pt/personal-inf...
@i3suporto.bsky.social
Camino is a visiting PhD Student from @ehu.eus working on development of MSC-based therapies for IBD. You can find more about her work at i3s.up.pt/personal-inf...
@i3suporto.bsky.social
Meet our group member Virgilio Piccolo!
Virgilio is a PhD Student at Univerisity of Naples Federico II. He is currently working on cancer nanomedicines for RNA delivery.
Find more about work at lnkd.in/eAaBDj2h
In free time, Virgilio likes to listen music, watch films and drink beer with friends.
Virgilio is a PhD Student at Univerisity of Naples Federico II. He is currently working on cancer nanomedicines for RNA delivery.
Find more about work at lnkd.in/eAaBDj2h
In free time, Virgilio likes to listen music, watch films and drink beer with friends.
September 12, 2026 at 9:06 AM
Meet our group member Virgilio Piccolo!
Virgilio is a PhD Student at Univerisity of Naples Federico II. He is currently working on cancer nanomedicines for RNA delivery.
Find more about work at lnkd.in/eAaBDj2h
In free time, Virgilio likes to listen music, watch films and drink beer with friends.
Virgilio is a PhD Student at Univerisity of Naples Federico II. He is currently working on cancer nanomedicines for RNA delivery.
Find more about work at lnkd.in/eAaBDj2h
In free time, Virgilio likes to listen music, watch films and drink beer with friends.
Honored to participate as Plenary Speaker at #IPTS2026 in Ankara, discuss biologics formulation and interface between nanobiotechnology and advanced drug delivery. Thanks to organizers, particularly Prof. Erem Bilensoy, for the invitation and a stimulating meeting. ipts-hacettepe.org
September 10, 2026 at 2:07 PM
Honored to participate as Plenary Speaker at #IPTS2026 in Ankara, discuss biologics formulation and interface between nanobiotechnology and advanced drug delivery. Thanks to organizers, particularly Prof. Erem Bilensoy, for the invitation and a stimulating meeting. ipts-hacettepe.org
Honoured to receive an Honorary Doctorate from the University of Buenos Aires. This distinction reflects a journey built on collaboration, outstanding colleagues, dedicated team members and the support of institutions that made our scientific ambitions possible.
www.ffyb.uba.ar/bruno-sarmen...
www.ffyb.uba.ar/bruno-sarmen...
September 4, 2026 at 9:10 PM
Honoured to receive an Honorary Doctorate from the University of Buenos Aires. This distinction reflects a journey built on collaboration, outstanding colleagues, dedicated team members and the support of institutions that made our scientific ambitions possible.
www.ffyb.uba.ar/bruno-sarmen...
www.ffyb.uba.ar/bruno-sarmen...
Intersection of gene therapy and nanomedicine for intestinal fibrosis, a major unmet challenge in #IBD @J Control Release
doi.org/10.1016/j.jc...
Moving beyond controlling inflammation towards molecular reprogramming of fibrotic pathways with RNA therapeutics and targeted nanodelivery.
doi.org/10.1016/j.jc...
Moving beyond controlling inflammation towards molecular reprogramming of fibrotic pathways with RNA therapeutics and targeted nanodelivery.
Redirecting
doi.org
August 7, 2026 at 1:38 PM
Intersection of gene therapy and nanomedicine for intestinal fibrosis, a major unmet challenge in #IBD @J Control Release
doi.org/10.1016/j.jc...
Moving beyond controlling inflammation towards molecular reprogramming of fibrotic pathways with RNA therapeutics and targeted nanodelivery.
doi.org/10.1016/j.jc...
Moving beyond controlling inflammation towards molecular reprogramming of fibrotic pathways with RNA therapeutics and targeted nanodelivery.
A demanding year tough, rewarding, full of ups & downs, but a positive one overall. Our NTDD group @i3suporto.bsky.social took a day out in nature to relax, recharge & bond before a new, equally challenging year begins. Vacation days coming soon too!
July 27, 2026 at 2:05 PM
A demanding year tough, rewarding, full of ups & downs, but a positive one overall. Our NTDD group @i3suporto.bsky.social took a day out in nature to relax, recharge & bond before a new, equally challenging year begins. Vacation days coming soon too!
Reposted by Bruno Sarmento
GlioBrain-Plate, an i3S-led project, aims to develop a pre-clinical platform to test new therapies targeting solid brain tumors. Now that the team has finished HiTech 2026, the project is ready for the next step toward reaching the market.
📰👀👇
#i3Sresearch #i3Sinnovation
📰👀👇
#i3Sresearch #i3Sinnovation
i3S acelera valorização de terapias para tumores cerebrais
Investigadoras do instituto concluíram um dos principais programas nacionais de transferência de tecnologia para projetos de investigação.
tinyurl.com
July 23, 2026 at 1:52 PM
GlioBrain-Plate, an i3S-led project, aims to develop a pre-clinical platform to test new therapies targeting solid brain tumors. Now that the team has finished HiTech 2026, the project is ready for the next step toward reaching the market.
📰👀👇
#i3Sresearch #i3Sinnovation
📰👀👇
#i3Sresearch #i3Sinnovation
It is a great honor to officially begin my term as President of
the Controlled Release Society. It was especially meaningful to be inducted in Portugal during #CRS2026. I look forward to work closely with the CRS community, the Board of Directors, and our members to advance the Society’s mission.
the Controlled Release Society. It was especially meaningful to be inducted in Portugal during #CRS2026. I look forward to work closely with the CRS community, the Board of Directors, and our members to advance the Society’s mission.
July 10, 2026 at 11:25 AM
It is a great honor to officially begin my term as President of
the Controlled Release Society. It was especially meaningful to be inducted in Portugal during #CRS2026. I look forward to work closely with the CRS community, the Board of Directors, and our members to advance the Society’s mission.
the Controlled Release Society. It was especially meaningful to be inducted in Portugal during #CRS2026. I look forward to work closely with the CRS community, the Board of Directors, and our members to advance the Society’s mission.
Great @CRSScience #CRS2026. Proud to share our work @i3S_UPorto and engage with drug delivery community as Tanja Weil, Chunying Chen, Paula Hammond, @NPeppas, Michael Bevilacqua and many others. Thanks to AMPC, led by Helena Florindo, and everyone who made this meeting a success.
July 10, 2026 at 10:23 AM
Great @CRSScience #CRS2026. Proud to share our work @i3S_UPorto and engage with drug delivery community as Tanja Weil, Chunying Chen, Paula Hammond, @NPeppas, Michael Bevilacqua and many others. Thanks to AMPC, led by Helena Florindo, and everyone who made this meeting a success.
The #CRS2026 Annual Meeting is almost here! Our group will contribute with multiple oral presentations, posters and chaired sessions. Privilege to welcome the global delivery science community in #Lisbon and a great honour to begin my term as President @CRSScience. See you there!
CRS 2026 Annual Meeting & Exposition
crs2026annualmeeting.eventscribe.net
July 4, 2026 at 9:10 AM
Honored to be the Opening Keynote Speaker at the #CRAFT2026 Research Symposium in #Toronto. Excited to share our latest advances in microengineered 3D multicompartmental platforms for drug screening across complex tissue and disease models.
#Nanomedicine #BiomedicalEngineering
#Nanomedicine #BiomedicalEngineering
June 19, 2026 at 2:22 AM
Honored to be the Opening Keynote Speaker at the #CRAFT2026 Research Symposium in #Toronto. Excited to share our latest advances in microengineered 3D multicompartmental platforms for drug screening across complex tissue and disease models.
#Nanomedicine #BiomedicalEngineering
#Nanomedicine #BiomedicalEngineering
Lovely 2026 NTDD Retreat! Hosted at Pharmacy Museum, we had a testimonial from Dr José Brito da Silva @IPOPorto on treating colorectal cancer patients, inspiring roundtable with NTDD alumni on life during and after PhD, team-building fun, and Santo António “sardinhada” at sunset
June 14, 2026 at 9:43 AM
Lovely 2026 NTDD Retreat! Hosted at Pharmacy Museum, we had a testimonial from Dr José Brito da Silva @IPOPorto on treating colorectal cancer patients, inspiring roundtable with NTDD alumni on life during and after PhD, team-building fun, and Santo António “sardinhada” at sunset
Our latest study, led by Sofia Dias, establishes a 3D multicellular intestinal model with capillary-like flow that better predicts drug permeability compared with conventional 2D systems and represent a promising #NAMs for early-stage drug development.
lnkd.in/etPU2wi2
lnkd.in/etPU2wi2
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
June 6, 2026 at 8:38 PM
Our latest study, led by Sofia Dias, establishes a 3D multicellular intestinal model with capillary-like flow that better predicts drug permeability compared with conventional 2D systems and represent a promising #NAMs for early-stage drug development.
lnkd.in/etPU2wi2
lnkd.in/etPU2wi2
Meet our group member Maria João!
Maria João is Junior Researcher working on anisotropic nanoparticles, mucus transport, diabetes, biopharmaceuticals, oral delivery. You can find more about her work at www.i3s.up.pt/personal-inf... #nanomedicine #drugdelivery #mucosalsurfaces @i3suporto.bsky.social
Maria João is Junior Researcher working on anisotropic nanoparticles, mucus transport, diabetes, biopharmaceuticals, oral delivery. You can find more about her work at www.i3s.up.pt/personal-inf... #nanomedicine #drugdelivery #mucosalsurfaces @i3suporto.bsky.social
June 2, 2026 at 8:50 PM
Meet our group member Maria João!
Maria João is Junior Researcher working on anisotropic nanoparticles, mucus transport, diabetes, biopharmaceuticals, oral delivery. You can find more about her work at www.i3s.up.pt/personal-inf... #nanomedicine #drugdelivery #mucosalsurfaces @i3suporto.bsky.social
Maria João is Junior Researcher working on anisotropic nanoparticles, mucus transport, diabetes, biopharmaceuticals, oral delivery. You can find more about her work at www.i3s.up.pt/personal-inf... #nanomedicine #drugdelivery #mucosalsurfaces @i3suporto.bsky.social
Almost closing 3 inspiring days at the @eufeps Annual Meeting in beautifull #Naples with my invited talk on our work on FcRn-targeted nanoplatforms for oral delivery of biologics. Thanks
Erem Bilensoy for the invitation and organizing the BABP session! annualmeeting.eufeps.org
Erem Bilensoy for the invitation and organizing the BABP session! annualmeeting.eufeps.org
May 29, 2026 at 6:38 AM
Almost closing 3 inspiring days at the @eufeps Annual Meeting in beautifull #Naples with my invited talk on our work on FcRn-targeted nanoplatforms for oral delivery of biologics. Thanks
Erem Bilensoy for the invitation and organizing the BABP session! annualmeeting.eufeps.org
Erem Bilensoy for the invitation and organizing the BABP session! annualmeeting.eufeps.org
Honored to open the 22nd European Drug Absorption Network meeting tonight as Plenary Speaker at
@universitysofia on “Shuttles, Shortcuts & Functional Nanocarriers for Oral Protein Delivery.”
Thanks Zahari Vinarov for invitation and excellent organization.
#Nanomedicine #EDAN
@universitysofia on “Shuttles, Shortcuts & Functional Nanocarriers for Oral Protein Delivery.”
Thanks Zahari Vinarov for invitation and excellent organization.
#Nanomedicine #EDAN
May 17, 2026 at 8:30 PM
Honored to open the 22nd European Drug Absorption Network meeting tonight as Plenary Speaker at
@universitysofia on “Shuttles, Shortcuts & Functional Nanocarriers for Oral Protein Delivery.”
Thanks Zahari Vinarov for invitation and excellent organization.
#Nanomedicine #EDAN
@universitysofia on “Shuttles, Shortcuts & Functional Nanocarriers for Oral Protein Delivery.”
Thanks Zahari Vinarov for invitation and excellent organization.
#Nanomedicine #EDAN
SUPERATE project is working to change that. Our main goal is to develop mucodiffusive anisotropic nanoparticles for the oral delivery of antidiabetic peptides, improving their oral bioavailability and paving the way for more patient-friendly therapies.
May 13, 2026 at 10:16 PM
SUPERATE project is working to change that. Our main goal is to develop mucodiffusive anisotropic nanoparticles for the oral delivery of antidiabetic peptides, improving their oral bioavailability and paving the way for more patient-friendly therapies.
Honored to attend #CRSBrazil2026 in #Goiania and participate in round table discussions on rational design and translational in drug delivery, with excellent line-up of international speakers. Thanks to @brazilcrs and Eliana Lima for outstanding organization.
www.even3.com.br/e/crs-brazil...
www.even3.com.br/e/crs-brazil...
May 7, 2026 at 7:37 PM
Honored to attend #CRSBrazil2026 in #Goiania and participate in round table discussions on rational design and translational in drug delivery, with excellent line-up of international speakers. Thanks to @brazilcrs and Eliana Lima for outstanding organization.
www.even3.com.br/e/crs-brazil...
www.even3.com.br/e/crs-brazil...
Congratulations to Ana Baião on successfully defending her PhD! Her work on the development of a novel combination therapy for colorectal cancer, combining CD44v6-targeted chemotherapy with immunotherapy, is truly remarkable. Well-done!
@i3suporto.bsky.social ICBAS #nanomedicines
@i3suporto.bsky.social ICBAS #nanomedicines
May 4, 2026 at 3:14 PM
Congratulations to Ana Baião on successfully defending her PhD! Her work on the development of a novel combination therapy for colorectal cancer, combining CD44v6-targeted chemotherapy with immunotherapy, is truly remarkable. Well-done!
@i3suporto.bsky.social ICBAS #nanomedicines
@i3suporto.bsky.social ICBAS #nanomedicines
Two recent collaborative publications on advancing nanomedicine! Original work on drug delivery across the BBB through post-insertion functionalization of lipid nanocapsules with cannabidiol using click chemistry doi.org/10.1016/j.co...
April 26, 2026 at 5:55 PM
Two recent collaborative publications on advancing nanomedicine! Original work on drug delivery across the BBB through post-insertion functionalization of lipid nanocapsules with cannabidiol using click chemistry doi.org/10.1016/j.co...
Honored to be inducted @aimbe-official.bsky.social College of Fellows. Recognition highlights my outstanding group in advancing bioengineered nanomedicines and biomimetic 3D multicompartmental tissue models. Looking forward to advocating for AIMBE!
aimbe.org/press/sarmen...
@i3suporto.bsky.social
aimbe.org/press/sarmen...
@i3suporto.bsky.social
April 13, 2026 at 5:31 PM
Honored to be inducted @aimbe-official.bsky.social College of Fellows. Recognition highlights my outstanding group in advancing bioengineered nanomedicines and biomimetic 3D multicompartmental tissue models. Looking forward to advocating for AIMBE!
aimbe.org/press/sarmen...
@i3suporto.bsky.social
aimbe.org/press/sarmen...
@i3suporto.bsky.social
These days in #Prague actively participating in the PBP World Meeting. This is a valuable opportunity to showcase our work within the #Genegut project and to explore collaborations around other 3D models we have developed. #worldmeeting
worldmeeting.org
worldmeeting.org
March 24, 2026 at 11:26 AM
These days in #Prague actively participating in the PBP World Meeting. This is a valuable opportunity to showcase our work within the #Genegut project and to explore collaborations around other 3D models we have developed. #worldmeeting
worldmeeting.org
worldmeeting.org
Congratulations to Helena Almeida for brilliantly defend her PhD on Engineering anisotropic nanoparticles as carriers for the oral administration of therapeutic peptides, Well-done!
@i3suporto.bsky.social @ICBAS #nanomedicines
@i3suporto.bsky.social @ICBAS #nanomedicines
March 13, 2026 at 4:44 PM
Congratulations to Helena Almeida for brilliantly defend her PhD on Engineering anisotropic nanoparticles as carriers for the oral administration of therapeutic peptides, Well-done!
@i3suporto.bsky.social @ICBAS #nanomedicines
@i3suporto.bsky.social @ICBAS #nanomedicines